Cognition Life Science (CLS), a new pharmaceutical company located in Tampa, Florida, has hired Dr Chuanhai Cao as Chief Scientific Officer and has acquired his intellectual property, which includes novel formulations to treat Alzheimer's Disease, Parkinson's Disease, sleep disorders and mental acuity.
Cao was one of the first scientists to determine that THC can halt and reverse the symptoms of Alzheimer's Disease. He developed a therapeutic vaccine for the treatment of Alzheimer's Disease and for certain forms of cancer.
CLS has issued Cao 13.5 million common shares and will pay him US$5m upon certain milestone achievements. Cao will be spending a some of his time attending to his duties at CLS and will be responsible for a budget in excess of $1m.
Cao is a research scientist at the College of Medicine Neurology and Assistant Professor of Cop. Department of Pharmaceutical Science at USF/Byrd Institute in Tampa, Florida.
